Phosphodiesterases (PDEs) serve as pivotal enzymes in cellular signaling by regulating cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels. Through the hydrolysis of these second messengers, PDEs influence numerous physiological processes including cell proliferation, inflammation, neuronal activity, and metabolism.

Exploring the Diversity of PDEs

The PDE enzyme family comprises multiple families and isoforms, each demonstrating distinct tissue distributions and substrate specificities. This diversity allows for targeted therapeutic opportunities, as selective modulation of individual PDE isoforms can result in desired clinical outcomes while minimizing potential side effects.

Our Cutting-Edge PDE Screening Services

Creative Bioarray provides high-throughput phosphodiesterase screening services leveraging state-of-the-art Fluorescence Polarization (FP) technology. This approach enables rapid identification of compounds that inhibit specific PDE subtypes, thereby accelerating the drug discovery process.

Mechanism of Action

The FP technology assesses the hydrolysis of fluorescently labeled substrates, such as cAMP or cGMP. When the substrate remains intact, it binds to antibodies forming larger complexes that yield high fluorescence polarization values. The hydrolysis by PDE reduces binding affinity, leading to diminished fluorescence polarization. The presence of inhibitory compounds prevents substrate hydrolysis, thus maintaining high fluorescence levels, indicating effective inhibition.

Key Detection Targets

We offer a wide range of PDE subtype screening services tailored to various research and development needs. Our detection targets include:

Service Features

• High-Throughput and Efficiency: Utilizing advanced FP technology, we facilitate the rapid screening of extensive compound libraries, significantly accelerating the discovery timeline.
• Precision and Reliability: Our systems are rigorously validated to guarantee accurate and reproducible data.
• Expert Support: Our dedicated team of specialists in pharmacology and enzymology provides comprehensive support in experimental design and data analysis.
• Tailored Solutions: We offer flexible and customizable experimental frameworks to meet client-specific requirements.

Conclusion

The screening of phosphodiesterases is essential in the landscape of drug discovery. Creative Bioarray is poised to advance your research with high-quality PDE screening services tailored to meet the dynamic needs of the pharmaceutical industry. For more information or to request a consultation, please contact our team today.